Dapagliflozin is an experimental drug being
studied by Bristol-Myers Squibb in partnership
as a potential treatment for
type 1 and 2 diabetes.
This product was researched by our company,
produced since 2008, and can large-scale
produced in 2009.
We're the largest supplier of this product in
China. And the quality beyond the international